Injective narxi

🔥 BULL MARKET TARGETS — NEW ALTCOINS 🚀 SEI — $5 ⚡ INJ — $100 🔗 AXL — $5 🌐 TIA — $20 💎 EIGEN — $20 🔥 RENDER — $20 🤖 FET — $10 🌊 APT — $30 💠 IMX — $10 🚀 OP — $10

Ethereum, XRP, Injective, Quant, and Pump.fun faced selling pressure as prices moved lower. Pump.fun and Quant recorded notable declines, while technical indicators showed weakening momentum across several assets. Let’s have a look at their latest price movements, important levels, and possible next moves. • Ethereum Faces More Pressure as MACD Remains Bearish Ethereum closed October 22 at $2,386.08, down 3.46%, after trading between $2,357.35 and $2,480.55. The decline erased Wednesday’s gains, pushed the price below the October 21 low of $2,434.51, and returned ETH to the lower part of its recent trading range. The daily MACD remained bearish, with the MACD line at -45.93 and the signal line at -36.31. The histogram widened to -9.61 from -9.01, showing that the gap between both lines had increased rather than moved toward a bullish crossover. The four-hour MACD also remained weak. Its line stood at -6.11, against a signal line of 0.70, while the histogram was -6.81. Although the short-term price recovered to $2,407.88, momentum has yet to confirm a reversal. For buyers to regain control, $ETH needs to close above $2,434.51. A move beyond $2,480.55 could open the way toward $2,524.58. On the downside, a close below $2,357.35 could expose $2,326.25 and the October 15 low of $2,313.42. Losing that low would weaken the developing base further. ETH traded 1.43% below the $2,443.19 price recorded in our October 21 report. • XRP Loses Support as Daily Volatility Increases XRP closed Thursday at $1.30798, falling 4.13% after reaching a low of $1.29391. The decline pushed the price below the $1.32990 support level mentioned in Thursday’s report, wiping out much of Wednesday’s recovery from the October 18 low. The 14-day Average True Range (ATR), calculated using Wilder smoothing, increased from $0.06348 to $0.06428. This represents 4.91% of the latest closing price and points to a slight increase in typical daily price movement. However, ATR measures volatility, not market direction, so its rise does not automatically mean further losses. The latest completed four-hour candle recovered to $1.32033, while the four-hour ATR stood at $0.02132. The recovery remained below $1.32990, meaning the broken support has not yet been reclaimed. A daily close above $1.32990 could improve the outlook, with $1.36865 and $1.39797 as the next levels to watch. If $XRP falls below $1.29391, the next level is $1.25477. A close below the October 18 low would weaken the recovery and bring the September 16 low of $1.24610 into focus. XRP’s latest completed daily close was 4.13% below the $1.36437 close analyzed in Thursday’s report. • Injective Momentum Weakens as RSI Moves Closer to Neutral Injective closed at $7.897, down 8.19%, after reaching a low of $7.846. This followed Wednesday’s close at $8.601 and brought the price closer to the $7.782–$7.846 support zone formed by the latest two swing lows. The daily Relative Strength Index (RSI), calculated over 14 periods using Wilder smoothing, dropped to 50.38 from 58.66. Although it remains slightly above the neutral 50 level, the decline shows that buying momentum has weakened. The four-hour RSI was lower at 46.52, indicating that short-term momentum had already moved below neutral. Despite the 8.19% decline during Thursday’s session, Injective gained 0.72% over the past 24 hours. These figures cover different time periods, so they do not necessarily contradict each other. A daily close above the $8.469–$8.642 range could improve the recovery outlook and bring $9.406–$9.490 into focus. However, a close below $7.782 could expose $7.28, followed by the October 8 low of $6.413. A clear drop in RSI below 50 would support the bearish outlook, although price movement would still need to confirm it. • Quant Slips Below Its Shorter-Term EMA Quant closed October 22 at $187.09, down 8.59%, after trading between $185.50 and $208.78. The decline erased Wednesday’s move above $200 and brought the price closer to the October 18 low of $181.15. The 20-day Exponential Moving Average (EMA) fell to $203.51 from $205.24, while the 50-day EMA increased to $169.48 from $168.77. Quant ended the session between these two averages. The 20-day EMA remains above the 50-day EMA, meaning a new bearish crossover has not occurred. However, the price has fallen below the shorter-term average, suggesting that near-term pressure has increased. The four-hour chart also showed weakness. The latest completed candle closed at $189.32, below the 20-period EMA at $194.94 and the 50-period EMA at $200.88. A daily close above the 20-day EMA could improve the outlook, with $208.78 and $213 as the next levels to watch. On the downside, a close below $185.50 could expose $181.15. If that level fails, attention may shift toward the rising 50-day EMA, which will continue to change as new daily candles form. • Pump.fun Struggles to Recover Within Its Bollinger Bands Pump.fun closed at $0.004546, down 11.19%, after failing to maintain Wednesday’s recovery. The price reached $0.005203 before dropping to $0.004505, leaving resistance around $0.005119–$0.005218. The daily Bollinger Bands, based on a 20-day simple moving average and two population standard deviations, showed a midpoint of $0.005255. The upper band stood at $0.006734, while the lower band was $0.003776. $PUMP closed in the lower half of the bands but remained above the lower boundary. This shows that the price has weakened without yet reaching the lower band. The latest completed four-hour candle recovered to $0.004646 but remained below the four-hour Bollinger midpoint of $0.004722. As a result, the bounce has not confirmed a return to the upper half of the bands on either timeframe. A daily close above $0.005119–$0.005218 could strengthen the recovery and bring the daily midpoint of $0.005255 into focus. If the price closes below $0.004505, the next downside levels are $0.004153 and $0.003788. A break below $0.003788 would weaken the recovery from the October low and bring the current lower band into focus. Pump.fun traded 1.98% below the $0.0047416 price recorded in Wednesday’s report.

🎯 FUTURES WATCHLIST — 4 LONGS + 1 SHORT 🟢 1. NEARUSDT Perp — LONG Current Price: $5.198 Entry: $5.150 – $5.200 SL: $4.980 TP1: $5.300 TP2: $5.420 TP3: $5.580 TP4: $5.750 🟢 2. ZEREBROUSDT Perp — LONG Current Price: $0.028203 Entry: $0.02780 – $0.02825 SL: $0.02640 TP1: $0.02910 TP2: $0.03020 TP3: $0.03150 TP4: $0.03300 🟢 3. USELESSUSDT Perp — LONG Current Price: $0.16332 Entry: $0.16100 – $0.16350 SL: $0.15400 TP1: $0.16800 TP2: $0.17400 TP3: $0.18200 TP4: $0.19100 🟢 4. PEPEUSDT Perp — LONG Current Price: $0.0000045221 Entry: $0.0000044800 – $0.0000045300 SL: $0.0000043200 TP1: $0.0000046500 TP2: $0.0000048000 TP3: $0.0000050000 TP4: $0.0000052500 🔴 5. INJUSDT Perp — SHORT Current Price: $8.473 Entry: $8.450 – $8.550 SL: $8.820 TP1: $8.300 TP2: $8.120 TP3: $7.900 TP4: $7.600 ⚡ DOUBLE SIGNAL — NEARUSDT 🟢 LONG SIGNAL Entry 1: $5.160 Entry 2: $5.280 SL: $4.980 TP1: $5.300 TP2: $5.420 TP3: $5.580 TP4: $5.750 🔴 SHORT SIGNAL Entry 1: $5.220 Entry 2: $5.080 SL: $5.350 TP1: $5.050 TP2: $4.920 TP3: $4.780 TP4: $4.600 $NEAR $USELESS $PEPE

$GRVT Injective has signed a memorandum of understanding with BDACS, a South Korean digital asset custodian, to support a won-backed stablecoin for tokenized asset trading on its network. The initiative is designed to give institutions a Korean won settlement option, potentially reducing reliance on US dollar stablecoins for activities tied to real-world assets (RWAs). Under the arrangement announced Tuesday, BDACS’s KRW1 stablecoin would act as the exclusive won-denominated settlement asset for RWAs on Injective. That means approved market participants could trade and settle tokenized assets directly in Korean won, rather than routing transactions through dollar-pegged stablecoins. Key takeaways Injective will use BDACS’s won-backed KRW1 as the exclusive settlement asset for RWAs on its tokenized asset markets. BDACS says KRW1 is fully backed by Korean won reserves, with minting and redemption initially limited to approved institutional partners. The program is tied to South Korea’s broader regulatory work on won-backed stablecoins under the proposed Digital Asset Basic Act. South Korean exchanges have reportedly seen net stablecoin outflows for 18 straight months through June, according to industry data cited by Cointelegraph. Injective has been expanding institutional infrastructure, including US SEC registration as a transfer agent for its institutional services arm. A won settlement layer for tokenized assets Stablecoins remain central to how crypto markets handle fast settlement, but most of the ecosystem is still heavily oriented around the US dollar. Injective’s agreement with BDACS aims to change that for at least one important use case: institutional trading and settlement of tokenized real-world assets on a layer-1 network. BDACS states that KRW1 is “fully backed” by Korean won reserves. The memorandum also specifies that minting and redemption would initially be limited to approved institutional partners, subject to regulatory approval. For investors and institutions, the operational difference is straightforward: if tokenized assets can settle in KRW instead of US dollars, the workflow can better match local cash management and reduce exposure to cross-currency settlement frictions. While the details of implementation are still contingent on approvals, the scope of the plan is notable. Injective is positioning KRW1 not as a secondary token option, but as the exclusive won-denominated settlement asset for RWAs on its platform under the agreement. Regulation in South Korea is the swing factor The BDACS–Injective memo arrives as South Korea continues building out a legal framework for won-backed stablecoins. Lawmakers are working on the proposed Digital Asset Basic Act, which the government aims to finalize by the end of 2026. Until that framework is in place, practical rollout is likely to depend on how regulators define issuers, licensing pathways, disclosures, and operational limits. A July policy report by Hashed Open Research and the Solana Policy Institute argued for more flexibility in stablecoin issuance while legislation is developed, including interim licensing guidance. According to Cointelegraph, the proposed law would create a broader regulatory structure for digital assets—covering stablecoin issuance rules, disclosure requirements, and market conduct. This matters because stablecoin issuance typically brings two intertwined risks for regulators: reserve management (including proof of backing and redemption processes) and market integrity (including who can issue, how transparency works, and how stablecoins interact with broader financial systems). Injective’s involvement, framed around settlement for tokenized RWAs, adds another regulatory layer—since tokenized assets can themselves touch securities and market-structure questions. South Korea’s stablecoin regulatory efforts also sit in a global context. The article notes the US GENIUS Act, which established a federal regulatory framework for payment stablecoins, and the European Union’s MiCA rules for stablecoin issuers. Together, these developments highlight a wider trend: stablecoins are increasingly moving from “informal market infrastructure” toward a regulated financial instrument category. Why won-backed stablecoins are gaining attention Even with regulatory momentum worldwide, stablecoin supply remains heavily dollar-led. Industry data cited by Cointelegraph via Stablecoin Beat indicates that dollar-backed tokens make up more than 99% of total stablecoin supply. That imbalance helps explain why institutions outside the US often face operational and risk-management challenges when they want crypto-native settlement but prefer local currency handling. Cointelegraph also points to ongoing demand and flow signals from South Korea. It cites industry data showing the country’s five largest crypto exchanges recorded net stablecoin outflows for 18 consecutive months through June. While the memorandum does not directly attribute causes for those outflows, the trend suggests that Korean market participants may have been moving stablecoin liquidity offshore rather than keeping settlement assets within local won-denominated rails. A won-backed settlement asset, if it scales, could address part of that friction. Rather than relying on US dollar stablecoins for tokenized asset settlement, institutions could align trading and settlement with Korean won, which may reduce certain conversion steps and allow more direct integration with local banking and treasury processes—assuming regulators and approved partners can operate within the compliance regime. Injective’s institutional push and next steps to watch Injective is not new to institutional-oriented infrastructure. In August, its institutional services arm registered with the US Securities and Exchange Commission as a transfer agent, enabling it to maintain ownership records and help facilitate securities transfers. That step aligns with Injective’s broader push to support tokenized securities and other RWA-related markets, where recordkeeping and operational controls are especially important. Cointelegraph also reports Injective’s native token market capitalization as roughly $887 million, based on CoinMarketCap data. While token valuation is not directly related to the KRW1 memo’s technical feasibility, it can affect market confidence and liquidity—factors that matter if institutions expect robust trading conditions around tokenized asset workflows. For now, the most important uncertainty is timing and permissibility. The KRW1 settlement role is tied to regulatory approval, and BDACS says minting and redemption will initially be restricted to approved institutional partners. Readers should watch for how South Korea’s stablecoin rules clarify eligibility for issuers and redemption systems, and whether interim licensing guidance (discussed in the July policy report) accelerates the path from memorandum to real settlement usage. If South Korea’s regulatory process stays on schedule and approved institutions begin using KRW1 for tokenized RWA settlement on Injective, the development could become a practical alternative to dollar-centric stablecoin settlement. The key question is whether regulators will enable enough market participants—and enough mint/redemption throughput—to make won-backed settlement a scalable option rather than a limited pilot. This article was originally published as Injective and BDACS Move to Settle Tokenized Assets in KRW Stablecoin on Crypto Breaking News – your trusted source for crypto news, Bitcoin news, and blockchain updates.